HOME >> BIOLOGY >> NEWS
4th MIM Pan-African Malaria Conference - Roll Back Malaria Partnership's Forum V Global Partners Meeting

As malaria deaths remain at alarming levels in Africa - with a child succumbing every 30 seconds and the devastating disease a root cause of the continent's pervasive poverty - an unprecedented gathering will convene in Africa to highlight new findings emerging from the work of Western and African malaria researchers.

In mid-November, 1,500 scientists, policymakers, African ministers, health care workers, community members, and other experts on the diseases will gather in Yaound, Cameroon, for the Fourth MIM Pan-African Malaria Conference November 13 - 18 and the Roll Back Malaria Partnership's Forum V Global Partners Meeting November 18 - 19. The conferences will collectively highlight an Africa-wide effort to empower communities, battle complacency and eliminate the many barriers that are keeping effective prevention and treatment from reaching the most vulnerable. The Roll Back Malaria Partnership will report on a coordinated plan to reduce malaria deaths in Africa and worldwide. Journalist site visits to research projects and malaria endemic communities will be organized prior to the conference.

This assembly offers a unique opportunity to find in one venue the world's leading experts on all aspects of malaria from prevention to control and from basic research to program implementation, as they tackle pressing scientific, social and economic issues confronting efforts to subdue the disease. Issues to be addressed include:

  • New medicines for malaria: With drug resistance spreading, scientists report on new advances in drugs to control malaria.
  • Indigenous plants as sources for new anti-malarials: Is there another Artemisia out there? Results of collection and screening efforts for anti-malarial agents in dozens of plants.
  • Country level commitment to malaria control: Leadership and ownership are essential if malaria is to become no longer "a fact of life".
  • Insecticid
    '"/>



12-Sep-2005


Page: 1 2 3

Related biology news :

1. Malaria -- Effective insecticide-repellent synergy against mosquito vectors
2. Malaria-resistant mosquitoes battle disease with molecular warhead
3. Malaria and Epstein-Barr virus linked to pediatric cancer in Africa
4. Malaria in pregnancy: What can the social sciences contribute?
5. Malaria: The right vaccine in the right place?
6. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
7. 20 Years of Malaria Research: Outcomes and Perspectives
8. Malaria poses additional risks for first-time mothers
9. Malaria drug may treat metabolic syndromes many symptoms
10. Malaria: Efficacy of monotherapies in Cameroon
11. Malaria, potato famine pathogen share surprising trait

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: